Cardiac T1 mapping in congenital heart disease: bolus vs. infusion protocols for measurements of myocardial extracellular volume fraction

N Al-Wakeel-Marquard, S Rastin, F Muench… - … International Journal of …, 2017 - Springer
Myocardial extracellular volume fraction (ECV) reflecting diffuse myocardial fibrosis can be
measured with T1 mapping cardiovascular magnetic resonance (CMR) before and after the …

[HTML][HTML] Single bolus versus split dose gadolinium administration in extra-cellular volume calculation at 3 Tesla

AK McDiarmid, PP Swoboda, B Erhayiem… - Journal of …, 2015 - Springer
Background Diffuse myocardial fibrosis may be quantified with cardiovascular magnetic
resonance (CMR) by calculating extra-cellular volume (ECV) from native and post-contrast …

T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique

SK White, DM Sado, M Fontana, SM Banypersad… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives: The aim of this study was to determine the accuracy of the contrast “bolus only”
T1 mapping cardiac magnetic resonance (CMR) technique for measuring myocardial …

[HTML][HTML] Comparison of canine ECV measurements derived from CMR: bolus injection vs. slow infusion of Gd-BOPTA

K Hong, EG Kholmovski, CJ McGann, R Ranjan… - Journal of …, 2014 - Springer
Background Myocardial extracellular volume (ECV) fraction [1], derived from pre-and post-
contrast cardiac T 1 measurements, is an emerging biomarker of diffuse cardiac fibrosis. The …

[HTML][HTML] Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus …

EB Schelbert, SM Testa, CG Meier, WJ Ceyrolles… - Journal of …, 2011 - Elsevier
Background Myocardial extravascular extracellular volume fraction (Ve) measures quantify
diffuse fibrosis not readily detectable by conventional late gadolinium (Gd) enhancement …

[HTML][HTML] Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker …

CM de Ravenstein, C Bouzin, S Lazam, J Boulif… - Journal of …, 2015 - Elsevier
Abstract Background Gadolinium (Gd) Extracellular volume fraction (ECV) by
Cardiovascular Magnetic Resonance (CMR) has been proposed as a non-invasive method …

Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions

TG Neilan, OR Coelho-Filho, RV Shah… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives: This study aimed to test the characteristics of the myocardial extracellular volume
fraction (ECV) derived from pre-and post-contrast T1 measurements among healthy …

myocardial extracellular volume imaging by MRI quantitatively characterizes myocardial infarction and subclinical myocardial fibrosis

M Ugander, AJ Oki, LY Hsu, P Kellman, A Greiser… - 2010 - Am Heart Assoc
Background: Imaging of fibrosis by cardiovascular magnetic resonance (CMR) is routinely
performed using late gadolinium enhancement (LGE). However, LGE imaging only …

Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans

AS Flett, MP Hayward, MT Ashworth, MS Hansen… - Circulation, 2010 - Am Heart Assoc
Background—Diffuse myocardial fibrosis is a final end point in most cardiac diseases. It is
missed by the cardiovascular magnetic resonance (CMR) late gadolinium enhancement …

[HTML][HTML] Non-invasive measurement of myocardial extracellular volume using T1 mapping as a novel biomarker of diffuse fibrosis in dilated cardiomyopathy

F aus dem Siepen, SA Seitz, E Giannitsis… - Journal of …, 2013 - journalofcmr.com
Background Diffuse myocardial fibrosis is frequently observed in histologies of dilated
cardiomyopathy (DCM). T1-mapping techniques have the potential to measure fibrosis …